BMY Bristol-Myers Squibb Company
Healthcare$58.17+0.00%OpenMarket Cap: $118.79B
As of 2026-05-26
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
 VETS | 8,348,045 | 13.24% | |
 SLT | Pacer Salt High truBeta US Market ETF | 8,348,045 | 13.24% |
 TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 8,348,045 | 13.24% |
 LSLT | Pacer Salt Low truBeta US Market ETF | 8,348,045 | 13.24% |
 VIRS | 8,348,045 | 13.24% | |
 AFTY | Pacer CSOP FTSE China A50 ETF | 11,049,374 | 5.97% |
 RDIV | Invesco S&P Ultra Dividend Revenue ETF | 853,002 | 5.36% |
 MEDX | Horizon Kinetics Medical ETF | 15,348 | 5.14% |
 KTD | 763,754 | 4.69% | |
 IHE | iShares U.S. Pharmaceuticals ETF | 763,754 | 4.69% |
 PPH | VanEck Pharmaceutical ETF | 992,569 | 4.61% |
 CANC | Tema Oncology ETF | 100,366 | 3.67% |
 DHSP LN | 103,786 | 3.61% | |
 DHSF IM | 103,413 | 3.61% | |
 LNGR | Global X Aging Population ETF | 18,552 | 3.56% |
 CAMX | Cambiar Aggressive Value ETF | 44,072 | 3.40% |
 CNCR | Loncar Cancer Immunotherapy ETF | 23,173 | 3.39% |
 SCHD | Schwab U.S. Dividend Equity ETF | 45,560,580 | 3.21% |
 PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 373,126 | 3.16% |
 PJP | Invesco Pharmaceuticals ETF | 191,641 | 2.96% |